Clomiphene citrate prevents premature luteinization in stimulated intrauterine insemination cycles

Nighat Sultana; Sadia Afrin Munmun; Dilruba Akhter; Mahamuda Yasmin; Shakeela Ishrat

doi:10.18203/2320-1770.ijrcog20242793

Authors

Nighat Sultana Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Sadia Afrin Munmun Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Dilruba Akhter Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Mahamuda Yasmin Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Shakeela Ishrat Department of Reproductive Endocrinology and Infertility, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh https://orcid.org/0000-0002-8568-0417

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242793

Keywords:

Clomiphene citrate, Intrauterine insemination, Premature LH surge, Premature luteinization

Abstract

Background: Approximately 13-36% of ovarian stimulation and intrauterine insemination cycles are complicated by premature luteinizing hormone (LH) surge. Gonadotropin releasing hormone (GnRH) agonist or antagonist has been traditionally used to prevent a premature LH surge and premature luteinization in ovarian stimulation cycles. Clomiphene citrate, which competitively inhibits estrogen binding to estrogen receptors, may be used to prevent premature luteinization and premature LH surge in ovarian stimulation with gonadotropins prior to intrauterine insemination (IUI). The objective was to compare the effects of clomiphene citrate with placebo on prevention of premature luteinization in ovarian stimulation with intrauterine insemination cycles.

Methods: This randomized controlled study was conducted from July 2021 to December 2022. A total of 76 participants had ovarian stimulation with tab letrozole and injection r-FSH. Transvaginal ultrasound for folliculometry was done from day 8 onwards as needed. When the leading follicle was at least 14 mm, women were randomly assigned to clomiphene citrate group (n=38) or placebo group (n=38). They were given clomiphene citrate 150 mg or placebo daily up to the day of trigger. Premature LH surge and premature luteinization were assessed on the day of trigger.

Results: Premature luteinization was significantly lower in patients given clomiphene citrate compared to women given placebo (16.7% versus 47.1%, p<0.01). Premature LH surge was also lower in participants given clomiphene citrate but the difference was not statistically significant (47.2% versus 52.9%, p<0.811). Pregnancy rate with clomiphene citrate was higher (11.1% versus 2.9%) than that with placebo.

Conclusions: The addition of clomiphene citrate to gonadotropins in mid to late follicular period decreases the risk of premature luteinization and improves pregnancy rate.

Metrics

Metrics Loading ...

References

Cohlen BJ. Should we continue performing intrauterine inseminations in the year 2004? Gynecol Obstet Invest. 2005; 59:3-13.

Cantineau AE, Janssen MJ and Cohlen BJ. Synchronized approach for intrauterine insemination in sub fertile couples. Cochrane Database Syst Rev. 2010; 14(4):006942. Doi: 10.1002/14651858.

Cantineau AE and Cohlen BJ. Dutch IUI Study Group. The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study. Fertil Steril. 2007; 88:107-12.

Bakas P, Konidaris S, Liapis A, Gregoriou O, Tzanakaki D and Creatsas G. Role of gonadotrophin-releasing hormone antagonist in the management of sub- fertile couples with intrauterine insemination and controlled ovarian stimulation. Fertil Steril. 2011; 95: 2024-28.

Manzi D, Dumez S, Scott L and Nulsen J. Selective use of leuprolide acetate in women undergoing superovulation with intrauterine insemination results in significant improvement in pregnancy outcome. Fertil Steril 1995; 63: 866–73.

Graziano A, Caserta D, Piva I, LO MONTE G, Bordi G, Martini F et al. The addition of GnRH antagonists in intrauterine insemination cycles: a pilot study. Eur Rev Med Pharmacol Sci, 2013; 17(12):1604-1610.

Merviel P, Heraud MH, Grenier N, Lourdel E, San-Guinet P and Copin H. Predictive factors for pregnancy after intrauterine insemination (IUI): An analysis of 1038 cycles and a review of the literature. Fertil Steril 2010; 93: 79-88.

Branigan EF and Estes MA. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Fertil Steril. 2000; 73:587-90.

Al-Inany H, Azab H, El-Khayat W, Nada A, El-Khattan E and Abou-Setta AM. The effectiveness of clomiphene citrate in LH surge suppression in women undergoing IUI: a randomized controlled trial. Fertil Steril. 2010; 94(6): 2167-71.

Schulz, K.F., Altman, D.G. and Moher, D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 2010; 1(2): 100-107.

Zarei A, Alborzi S, Askary E, Alborzi M and Shahbazi F. Effects of clomiphene citrate for prevention of premature luteinizing hormone surge in those undergoing intrauterine insemination outcome: A randomized, double-blind, placebo-controlled trial. J Adv Pharm Technol Res 2018; 9(3):87.

Shams-Eldeen NM, Shalan HM, Hemida RAH and Elmetwally AG. Clomiphene citrate in LH surge suppression for women undergoing ICSI. Middle East Fertil Soc J 2018; 23(4): 281-5.

Wadhwa L, Khanna R, Gupta T, Gupta S, Arora S and Nandwani S. Evaluation of role of GnRH antagonist in intrauterine insemination (IUI) cycles with mild ovarian hyperstimulation (MOH): a prospective randomized study. J Obstet Gynecol India 2016; 66(1): 459-65.

Dansuk R, Gonenc AI, Sudolmus S, Yucel O, Sevket O and Köroğlu N. Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination. Singapore Med J 2015; 56(6):353.

Steward RG, Gill I, Williams DB, Witz CA, Griffith J and Haddad GF. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction–intrauterine insemination cycles: a randomized-controlled clinical trial. Fertil and Steril, 2011; 95(1):434-6.

Matorras R, Ramón O, Expósito A, et al. Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. . J Assist Reprod Genet 2006; 23(2):51-4.

Vitagliano A, Saccone G, Noventa M, et al. Pituitary block with gonadotrophin releasing hormone antagonist during intrauterine insemination cycles: a systematic review and meta-analysis of randomized controlled trials. BJOG 2019; 126(2):167-75.

Karthik SDS, Kriplani A, Kachhawa G, Khadgawat R, Aggarwal N and Bhatla N. Comparison of two regimens of gonadotropin-releasing hormone antagonists in clomiphene-gonadotropin induced controlled ovulation and intrauterine insemination cycles: Randomized controlled study. . J Hum Reprod Sci 2018; 11(2): 148.

Gobernado J, Alvarez-Colomo C, Rodriguez-Tabernero L, Barrero L, Fernández-Gómez JMF and Schneider J. GnRH antagonist administration to postpone a weekend intrauterine insemination: a large cohort study from a public center. Reprod Biol Endocrinol 2016; 14(1):1-4.

Lambalk CB, Leader A, Olivennes F, et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod. 2006; 21(3):632-39.